Zargar, A., Gupta, S., Jaganmohan, B., Warrier, S., Farista, F., Patil, C., & Yadav, S. (2025). Patient-centered Assessment of the Efficacy and Safety of Vildagliptin Sustained-release Tablet (100 mg) Relative to Sitagliptin (100 mg) in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on MEtformin (PRIME-Vilda Trial). Medical Research Archives, 13(5). doi:10.18103/mra.v13i5.6599